Brind.
  1. Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.

Sooin was appointed Chief Business and Strategy Officer at Galapagos, which also announced a partnership with Gilead.

1 report, 1 independent Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sooin was appointed Chief Business and Strategy Officer at Galapagos, which also announced a partnership with Gilead.

Who's involved

What this event is mainly about
GalapagosGilead

Keep exploring

Part of

Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.

Also in this story

All 12 developments

The entities involved

  • Galapagos

    biotechnology company based in Leiden, Netherlands

    Nothing else this week.

  • Gilead

    ancient Israelite geographical location in modern day Jordan

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GlobeNewswireGalapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation Appoints Sooin Kwon as Chief Business Officer and Dan Grossman as Chief Strategy Officer